Performance of the preliminary definition of improvement in juvenile chronic arthritis patients treated with methotrexate

Annals of the Rheumatic Diseases

Volumn 57, Issue 1, 1998, Pages 38-41

  Ruperto, Nicolino ^a   Ravelli, Angelo ^a   Falcini, Fernanda ^b   Lepore, Loredana ^c   De Sanctis, Rosetta ^d   Zulian, Francesco ^e   Buoncompagni, Antonella ^f   Sardella, Maria Luisa ^g   Strano, Ciro ^h   Alessio, Maria ⁱ   Viola, Stefania ^a   Martini, Alberto ^a,j  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

^d BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^e Clinica Pediatrica I   (Italy)

^f G GASLINI INSTITUTE   (Italy)

^g UNIVERSITY OF TURIN   (Italy)

^h Clinica Pediatrica   (Italy)

ⁱ II Divisione di Pediatria   (Italy)

^j UNIVERSITY OF PAVIA   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE;

ADOLESCENT; ARTICLE; CHILD; CLINICAL TRIAL; DRUG EFFICACY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; INFANT; JOINT CHARACTERISTICS AND FUNCTIONS; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; OUTCOMES RESEARCH; PRIORITY JOURNAL; TREATMENT OUTCOME; WELLBEING;

EID: 15444352940     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.57.1.38     Document Type: Article

References (13)

1. Ruperto N, Giannini EH. Redundancy of conventional articular response variables used in juvenile chronic arthritis clinical trials. Ann Rheum Dis 1996;55:73-5.
2. Giannini EH, Lovell DJ, Felson DT, Goldsmith CH. Preliminary core set of outcome variables for use in JRA clinical trials. Arthritis Rheum 1994;37(suppl):S428.
3. Giannini EH, Ruperto N, Ravelli A, Lovell DJ, Felson DT, Martini A. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum 1997;40:1202-9.
4. 3a Ravelli A, Gerloni V, Corona F, Falcini F, Lepore L, De Sanctis R, et al. Oral versus intramuscular methotrexate in juvenile chronic arthritis. Clin Exp Rheumatol (in press).
5. Wood PHN. Special meeting on: nomenclature and classification of arthritis in children. In: Munthe E, ed. The care of rheumatic children. Basle: EULAR Publishers, 1987:47-50.
6. Ravelli A, Ruperto N, Ramenghi B, Aramini L, Martini A. Protocollo di valutazione del trattamento con methotrexate nell'artrite cronica giovanile (Standardized protocol for the assessment of methotrexate treatment in juvenile chronic arthritis). Revista Italiana di Pediatria (It J Pediatr) 1994;20:92-5.
7. Ravelli A, Viola S, Ramenghi B, Di Fuccia G, Ruperto N, Zonta L, et al. Evaluation of response to methotrexate by a functional index in juvenile chronic arthritis. Clin Rheumatol 1995;14:322-6.
8. Howe S, Levinson J, Shear E, Hartner S, McGirr G, Schulte M, et al. Development of a disability measurement tool for juvenile rheumatoid arthritis. The Juvenile Arthritis Functional Assessment Report for children and their parents. Arthritis Rheum 1991;34:873-80.
9. Singh G, Athreya BH, Fries JF, Goldsmith DP. Measurement of health status in children with juvenile rheumatoid arthritis. Arthritis Rheum 1994;37:1761-9.
10. Fantini F, Corvaglia G, Bergomi P, Gattinara M, Gerloni V, Lomater C, et al. Validation of the Italian version of the Stanford Childhood Health Assessment Questionnaire for measuring functional status in children with chronic arthritis. Clin Exp Rheumatol 1995;13:785-91.
11. Ravelli A, Viola S, Ruperto N, Corsi B, Ballardini G, Martini A. Correlation between conventional disease activity measures in juvenile chronic arthritis. Ann Rheum Dis 1997;56:197-200.
12. Giannini EH, Brewer EJ, Kuzmina N, Shaikov A, Maximov A, Vorontsov I, et al. Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. N Engl J Med 1992; 326:1043-9.
13. Buchbinder R, Bombardier C, Yeung M, Tugwell P. Which outcome measures should be used in rheumatoid arthritis clinical trials? Clinical and quality-of-life measures' responsiveness to treatment in a randomized controlled trial. Arthritis Rheum 1995;38:1568-80.